肝门部肝内胆管癌根治性切除的围手术期与长期结局:与周围型肝内胆管癌及肝门部胆管癌的比较
基于两个多中心数据库,纳入2000至2015年根治性切除的912例肿块型周围型肝内胆管癌、101例肝门部肝内胆管癌和159例肝门部胆管癌患者,比较三组临床病理特征及近远期结局。肝门部肝内胆管癌侵袭性更强、更常需扩大切除,淋巴结清扫率和R0率与肝门部胆管癌相当但高于周围型肝内胆管癌,技术相关并发症高于周围型肝内胆管癌,疾病特异性生存和无复发生存均劣于后两者。结论认为肝门部肝内胆管癌是侵袭性更强的胆管癌亚型。
要点
- 肝门部肝内胆管癌血管侵犯和淋巴结转移频率更高,需更广泛切除。
- 其淋巴结清扫率和R0率与肝门部胆管癌相当,但高于周围型肝内胆管癌。
- 根治性切除后疾病特异性生存和无复发生存均劣于周围型和肝门部胆管癌。
核心结论
- 肿块型肝内胆管癌累及肝门是侵袭性更强的胆管癌类型,临床病理特征独特,根治性切除后长期结局劣于周围型肝内胆管癌和肝门部胆管癌。
研究设计与样本
- 多中心回顾性队列研究,纳入两个多机构数据库2000至2015年根治性切除的患者:912例肿块型周围型肝内胆管癌、101例肝门部肝内胆管癌和159例肝门部胆管癌。
主要发现
- 肝门部肝内胆管癌较周围型肝内胆管癌或肝门部胆管癌血管侵犯和淋巴结转移频率更高,切除范围更广泛。
- 肝门部肝内胆管癌淋巴结清扫率85.1%高于周围型肝内胆管癌42.5%(P < .001)。
- 肝门部肝内胆管癌R0切除率75.2%低于周围型肝内胆管癌88.8%(P < .001)。
- 肝门部肝内胆管癌技术相关并发症发生率高于周围型肝内胆管癌。
- 肝门部肝内胆管癌中位疾病特异性生存26.0个月,劣于周围型肝内胆管癌54.0个月(P < .001)和肝门部胆管癌49.0个月(P = .003);中位无复发生存13.0个月,劣于周围型肝内胆管癌18.0个月(P = .021)和肝门部胆管癌33.4个月(P < .001)。
临床怎么用
- 对肿块型肝内胆管癌应评估肝门受累情况,以便制定更积极的手术和淋巴结清扫策略。
- 肝门部肝内胆管癌根治性切除后需加强围手术期并发症管理,并密切随访监测复发。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Intrahepatic cholangiocarcinoma with hepatic hilus involvement has been either classified as intrahepatic cholangiocarcinoma or hilar cholangiocarcinoma. The present study aimed to investigate the clinicopathologic characteristics and short- and long-term outcomes after curative resection for hilar type intrahepatic cholangiocarcinoma in comparison with peripheral intrahepatic cholangiocarcinoma and hilar cholangiocarcinoma. METHODS: A total of 912 patients with mass-forming peripheral intrahepatic cholangiocarcinoma, 101 patients with hilar type intrahepatic cholangiocarcinoma, and 159 patients with hilar cholangiocarcinoma undergoing curative resection from 2000 to 2015 were included from two multi-institutional databases. Clinicopathologic characteristics and short- and long-term outcomes were compared among the 3 groups. RESULTS: Patients with hilar type intrahepatic cholangiocarcinoma had more aggressive tumor characteristics (eg, higher frequency of vascular invasion and lymph nodes metastasis) and experienced more extensive resections in comparison with either peripheral intrahepatic cholangiocarcinoma or hilar cholangiocarcinoma patients. The odds of lymphadenectomy and R0 resection rate among patients with hilar type intrahepatic cholangiocarcinoma were comparable with hilar cholangiocarcinoma patients, but higher than peripheral intrahepatic cholangiocarcinoma patients (lymphadenectomy incidence, 85.1% vs 42.5%, P < .001; R0 rate, 75.2% vs 88.8%, P < .001). After curative surgery, patients with hilar type intrahepatic cholangiocarcinoma experienced a higher rate of technical-related complications compared with peripheral intrahepatic cholangiocarcinoma patients. Of note, hilar type intrahepatic cholangiocarcinoma was associated with worse disease-specific survival and recurrence-free survival after curative resection versus peripheral intrahepatic cholangiocarcinoma (median disease-specific survival, 26.0 vs 54.0 months, P < .001; median recurrence-free survival, 13.0 vs 18.0 months, P = .021) and hilar cholangiocarcinoma (median disease-specific survival, 26.0 vs 49.0 months, P = .003; median recurrence-free survival, 13.0 vs 33.4 months, P < .001). CONCLUSION: Mass-forming intrahepatic cholangiocarcinoma with hepatic hilus involvement is a more aggressive type of cholangiocarcinoma, which showed distinct clinicopathologic characteristics, worse long-term outcomes after curative resection, in comparison with peripheral intrahepatic cholangiocarcinoma and hilar cholangiocarcinoma.
引用
- Zhang XF, Bagante F, Chen Q, et al. Perioperative and long-term outcome of intrahepatic cholangiocarcinoma involving the hepatic hilus after curative-intent resection: comparison with peripheral intrahepatic cholangiocarcinoma and hilar cholangiocarcinoma. Surgery. 2018. PMID: 29398035. doi:10.1016/j.surg.2018.01.001
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。